Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 7/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | MAT2A | P31153 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.36 |
| ▸ | PPARA | Q07869 | 2/20 | 0.36 |
| ▸ | GBA1 | P04062 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24125292 | 0.94 | ABCG2 (0.41) | ABCG2KIF11KDM4EATML3MBTL1 | |
| SCHEMBL22171718 | 0.92 | ABCG2 (0.40) | ABCG2KIF11KDM4EATML3MBTL1 | |
| SCHEMBL24125288 | 0.90 | ABCG2 (0.41) | ABCG2L3MBTL1MAT2ADHODHGBA1 | |
| SCHEMBL30107787 | 0.89 | ABCG2 (0.44) | ABCG2KIF11KDM4EATML3MBTL1 | |
| SCHEMBL21108728 | 0.88 | ABCG2 (0.42) | ABCG2KIF11ESR1DHODHGBA1 | |
| SCHEMBL23915050 | 0.86 | ABCG2 (0.39) | ABCG2KIF11KDM4EATML3MBTL1 | |
| SCHEMBL23915051 | 0.86 | ABCG2 (0.39) | ABCG2KIF11KDM4EATML3MBTL1 | |
| SCHEMBL24125765 | 0.85 | ABCG2 (0.38) | ABCG2KIF11ATML3MBTL1DHODH | |
| SCHEMBL19269995 | 0.85 | L3MBTL1 (0.52) | ABCG2KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL6372942 | 0.85 | L3MBTL1 (0.52) | ABCG2KDM4EATML3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542260-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2023-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11542260-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, NDUFV3, SLCO1B3 | ABCG2 112/4885KIF11 3616/4885KDM4E 4295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.